静脉-动脉体外膜氧合在大面积肺栓塞相关心脏骤停中的应用:系统评价
该系统评价纳入77篇文献共301例因大面积肺栓塞相关心脏骤停接受VA-ECMO的患者。61%(183/301)存活至出院,60例中53例(88%)出院或随访时神经功能完好。置管前接受全身溶栓与未接受者生存率无显著差异(67% vs 61%,p=0.48)。多因素分析显示年龄>65岁死亡风险增加三倍(aOR 3.08,p=0.03),CPR期间置管死亡风险增加六倍(aOR 5.67,p=0.03)。
要点
- 大面积肺栓塞相关心脏骤停接受VA-ECMO者出院生存率61%(183/301),提示该策略在特定患者中可行。
- 年龄>65岁与死亡风险增加三倍独立相关(aOR 3.08,p=0.03),置管决策需考虑年龄。
- CPR期间置管与死亡风险增加六倍独立相关(aOR 5.67,p=0.03),提示置管时机对预后影响显著。
- 置管前全身溶栓与未溶栓者生存率无显著差异(67% vs 61%,p=0.48),不因溶栓史排除ECMO。
- PE是否为入院主因(OR 1.62,p=0.35)及急诊科vs其他地点置管(OR 2.52,p=0.16)与死亡风险无显著相关。
适用人群与场景
- 纳入标准:所有报告因大面积肺栓塞相关心脏骤停接受VA-ECMO治疗患者出院生存情况的文献。
- 共纳入77篇文献、301例患者(总筛选1115篇)。
- 年龄>65岁者死亡风险增高(aOR 3.08,p=0.03);CPR期间置管者死亡风险增高(aOR 5.67,p=0.03)。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 原文未提及具体药物剂量、给药途径或ECMO管理方案。
- 置管前接受全身溶栓者(n=51)与未接受者生存率相似(67% vs 61%,p=0.48)。
- 急诊科置管与其他地点置管的死亡风险无显著差异(OR 2.52,p=0.16)。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:系统评价;纳入77篇文献、301例患者(总筛选1115篇)。
- 主要终点:61%(183/301)存活至出院。
- 神经功能:60例中53例(88%)出院或随访时神经功能完好。
- 置管前全身溶栓vs未溶栓生存率:67% vs 61%(p=0.48)。
- 多因素分析:年龄>65岁aOR 3.08(p=0.03);CPR期间置管aOR 5.67(p=0.03)。
- PE为入院主因与否的死亡OR 1.62(p=0.35);急诊科vs其他地点置管OR 2.52(p=0.16)。
证据类型、等级与局限
- 证据类型:系统评价(基于77篇文献的汇总分析)。
- 局限:纳入文献异质性未详细描述;部分分析样本量小(如神经功能仅60例);为观察性研究的系统评价,无法排除混杂。
对床旁实践的改变
- 大面积肺栓塞相关心脏骤停可考虑VA-ECMO,但需权衡年龄>65岁(死亡风险三倍)和CPR期间置管(死亡风险六倍)的不利因素。
- 置管前已接受全身溶栓不构成VA-ECMO的禁忌,两者生存率无显著差异。
- 急诊科置管并非独立危险因素,不应因地点延迟ECMO启动。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: Management of patients experiencing massive pulmonary embolism-related cardiac arrest is controversial. Venoarterial extracorporeal membranous oxygenation has emerged as a potential therapeutic option for these patients. We performed a systematic review assessing survival and predictors of mortality in patients with massive PE-related cardiac arrest with venoarterial extracorporeal membranous oxygenation use.
DATA SOURCES: A literature search was started on February 16, 2020, and completed on March 16, 2020, using PubMed, Embase, Cochrane Central, Cinahl, and Web of Science.
STUDY SELECTION: We included all available literature that reported survival to discharge in patients managed with venoarterial extracorporeal membranous oxygenation for massive PE-related cardiac arrest.
DATA EXTRACTION: We extracted patient characteristics, treatment details, and outcomes.
DATA SYNTHESIS: About 301 patients were included in our systemic review from 77 selected articles (total screened, n = 1,115). About 183 out of 301 patients (61%) survived to discharge. Patients (n = 51) who received systemic thrombolysis prior to cannulation had similar survival compared with patients who did not (67% vs 61%, respectively; p = 0.48). There was no significant difference in risk of death if PE was the primary reason for admission or not (odds ratio, 1.62; p = 0.35) and if extracorporeal membranous oxygenation cannulation occurred in the emergency department versus other hospital locations (odds ratio, 2.52; p = 0.16). About 53 of 60 patients (88%) were neurologically intact at discharge or follow-up. Multivariate analysis demonstrated three-fold increase in the risk of death for patients greater than 65 years old (adjusted odds ratio, 3.08; p = 0.03) and six-fold increase if cannulation occurred during cardiopulmonary resuscitation (adjusted odds ratio, 5.67; p = 0.03).
CONCLUSIONS: Venoarterial extracorporeal membranous oxygenation has an emerging role in the management of massive PE-related cardiac arrest with 61% survival. Systemic thrombolysis preceding venoarterial extracorporeal membranous oxygenation did not confer a statistically significant increase in risk of death, yet age greater than 65 and cannulation during cardiopulmonary resuscitation were associated with a three- and six-fold risks of death, respectively.
参考来源
- Scott JH, Gordon M, Vender R, et al. Venoarterial Extracorporeal Membrane Oxygenation in Massive Pulmonary Embolism-Related Cardiac Arrest: A Systematic Review. Crit Care Med. 2021. PMID: 33590996. doi:10.1097/CCM.0000000000004828
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。